Healthcare Stocks

Deals of the day-Mergers and acquisitions

  • December 01, 2022 08:02 AM PST | Reuters
 Deals of the day-Mergers and acquisitions

(Adds Axo, Univar Solutions, PLT Energia, Kronospan, Aerojet Rocketdyne, Vivendi; updates Telecom Italia) Nov 30 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by

Read More...

BRIEF-Flurotech Announces Strategic Exit Of Covid-19 Pandemic Testing Business

BRIEF-Flurotech Announces Strategic Exit Of Covid-19 Pandemic Testing Business

  • November 29, 2022 11:27 PM EST | Reuters

Nov 29 (Reuters) - FluroTech Ltd: * FLUROTECH ANNOUNCES STRATEGIC EXIT OF COVID-19 PANDEMIC TESTING BUSINESS * FLUROTECH LTD- OVER NEXT SIX MONTHS, FLUROTECH'S SUBSIDIARY WILL DISCONTINUE ITS BUSINESS

Read More...
BRIEF-Questor Announces Third Quarter Results

BRIEF-Questor Announces Third Quarter Results

  • November 29, 2022 11:24 PM EST | Reuters

Nov 29 (Reuters) - Questor Technology Inc: * QUESTOR ANNOUNCES THIRD QUARTER RESULTS * QUESTOR TECHNOLOGY INC - QTRLY LOSS PER SHARE C$0.00 * QUESTOR TECHNOLOGY INC - QTRLY REVENUE C$1.7 MILLION

Read More...
BRIEF-Medical Facilities Corp Approves Normal Course Issuer Bid

BRIEF-Medical Facilities Corp Approves Normal Course Issuer Bid

  • November 29, 2022 11:23 PM EST | Reuters

Nov 29 (Reuters) - Medical Facilities Corp: * MEDICAL FACILITIES CORPORATION ANNOUNCES APPROVAL OF NORMAL COURSE ISSUER BID Source text for Eikon: Further company coverage:

Read More...
BRIEF-Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003

BRIEF-Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003

  • November 29, 2022 11:22 PM EST | Reuters

Nov 29 (Reuters) - Tetra Bio Pharma Inc: * TETRA BIO-PHARMA PROVIDES UPDATE ON PATENT APPLICATIONS FOR NOVEL THERAPEUTIC ARDS-003 * TETRA BIO PHARMA INC - ANNOUNCED FILING OF THREE PATENT APPLICATIONS

Read More...
OrganiGram Holdings Inc <OGI.TO>: Losses of 2  cents announced for fourth quarter

OrganiGram Holdings Inc <OGI.TO>: Losses of 2  cents announced for fourth quarter

  • November 29, 2022 03:05 PM EST | Reuters

29 November 2022 04:04 a.m. ​All figures in Canadian dollars. The loss announced by OrganiGram Holdings Inc in the fourth quarter were on par with the Refinitiv mean estimate of losses. The company

Read More...
BRIEF-Organigram Reports Record Fourth Quarter And Full Year Fiscal 2022 Results

BRIEF-Organigram Reports Record Fourth Quarter And Full Year Fiscal 2022 Results

  • November 29, 2022 12:02 PM PST | Reuters

Nov 28 (Reuters) - Organigram Holdings Inc: * ORGANIGRAM REPORTS RECORD FOURTH QUARTER AND FULL YEAR FISCAL 2022 RESULTS * QTRLY NET REVENUE, REACHING $45.5 MILLION, UP 83% FROM $24.9 MILLION IN SAME

Read More...
OrganiGram Holdings Inc reports results for the quarter ended in August - Earnings Summary

OrganiGram Holdings Inc reports results for the quarter ended in August - Earnings Summary

  • November 29, 2022 02:51 PM EST | Reuters

* OrganiGram Holdings Inc reported a quarterly adjusted loss of 2 cents​​ per share for the quarter ended in August. The mean expectation of two analysts for the quarter was for a loss of 2 cents per

Read More...
What to Watch in the Day Ahead - Wednesday, November 30

What to Watch in the Day Ahead - Wednesday, November 30

  • November 30, 2022 06:30 AM AEDT | Reuters

(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at . Thomson One users

Read More...
BRIEF-Organigram Reports Record Fourth Quarter And Full Year Fiscal 2022 Results

BRIEF-Organigram Reports Record Fourth Quarter And Full Year Fiscal 2022 Results

  • November 29, 2022 12:02 PM EST | Reuters

Nov 28 (Reuters) - Organigram Holdings Inc: * ORGANIGRAM REPORTS RECORD FOURTH QUARTER AND FULL YEAR FISCAL 2022 RESULTS * QTRLY NET REVENUE, REACHING $45.5 MILLION, UP 83% FROM $24.9 MILLION IN SAME

Read More...
BRIEF-Neovasc Announces Progress On Cosira-II Clinical Trial

BRIEF-Neovasc Announces Progress On Cosira-II Clinical Trial

  • November 29, 2022 08:48 AM PST | Reuters

Nov 28 (Reuters) - Neovasc Inc: * NEOVASC ANNOUNCES PROGRESS ON COSIRA-II CLINICAL TRIAL * UNDERTAKEN SEVERAL INITIATIVES TO FURTHER ACCELERATE ENROLLMENT IN TRIAL * AIMS TO COMPLETE RANDOMIZATION IN

Read More...

Frequently Asked Questions

There are multiple ways to look at any stock. It may include looking at fundamentals like dividends, earnings over the last few years, and ratios like price-to-earnings (P/E). The other way might be to look at what the future may hold. In the event of a large-scale demand in the future for a particular drug or vaccine that a company has produced or is likely to produce in the near term, the company's stock may find more backers. A look at what the company provides in the market, which can include hospital services, might be a good way to look at healthcare stocks.

There is a variety of choices available to the investor. Stocks represent companies that operate in sectors like healthcare, oil and gas, cannabis, and the list is long. The best stocks may relate to a particular industry, for example, the clean energy sector which has participants like Brookfield Renewable Partners, and Northland Power, or they can be a diversified mix of clean energy stocks and other sectors like oil and energy. In order to pick the best, the investor must study a little about the near-term market prospects for the related sector.

Considering the market environment at the time of writing this, Verde Agritech PLC (TSX: NPK) appears to be one of the fastest-growing stocks in Canada, with a price-to-earnings (P/E) ratio of 114.3. This crop nutrition and input stock has zoomed by over 450 per cent in the last 12 months. On the financial front, Verde Agritech expanded its 2021 net profit by 540 per cent year-on-year (YoY), and it expects 2022 revenue to reach C$ 72.26 million. However, investors should note that a stock’s performance can change depending on market conditions.

Healthcare stocks represent entities that provide arguably one of the most basic necessities to the wider world. They become even more crucial at the time of a pandemic or a large-scale disease outbreak in any particular region. Healthcare remains a growing sector as cures for all diseases have yet to be identified, and new ones like Covid-19 can crop up at any time. This makes healthcare stocks an interesting watch for a lot of investors.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK